Understanding the Infectious Disease Process: Standard & Transmission Based Precautions Russ Olmsted Trinity Health - Livonia, MI Olmstedr@trinity-health.org Key Principles: It’s More Than Presence of the Microorganism Historical Milestones in Development of Infection Prevention & Control Precautions, U.S. 1877: Separate facilities for the “Infectious Patient” 1910: Antisepsis and disinfection 1950-60: Closure of Infectious disease and TB hospitals 1970: CDC “Isolation Techniques for use in Hospitals” 1983: CDC Guideline for Isolation Precautions in Hospitals (Disease-specific and category-based precautions including blood and body-fluids) 1985: Universal Precautions (Mostly focused on worker protection against bloodborne pathogens, e.g. HIV)” 1987 Body Substance Isolation (U WA team developed; concept was precursor to Standard Precautions (SP) – used for all patients) History of Infection Prevention & Control Precautions, U.S. 1996: Revised CDC Guidelines: Standard Precautions 2002: MSIPC Antimicrobial Resistant Organisms (ARO) Guidelines 2006: HICPAC, CDC; Management of Multidrug- 2007: HICPAC, CDC; Guideline for Isolation resistant Organisms (MDROs) in Healthcare Facilities Dec. – Dec. 2007 issue of AJIC vol. 35:S165-S173 Precautions: Preventing Transmission of Infectious Agents in Health Care Settings - Dec. 2007 issue of AJIC vol. 35:S65-S164 2006 MDRO & 2007 Isolation Precautions – must haves and full text available for all (non-subscribers too) at: http://www.ajicjournal.org Just a Word About Standard Precautions (SP) Used for all patients – even those on trans.-based precautions Assume that every person is potentially infected or colonized with an organism that could be transmitted in the health care setting Hand hygiene PPE: gloves, gown, mouth-nose-eye protection, etc. Respiratory hygiene / cough etiquette Patient placement Environmental cleaning and disinfection, soiled linen Safe injection practices SP: Precautions for Lumbar Puncture Surgical Mask: placing a catheter or injecting material spinal canal or subdural space (ie, myelograms, LP, & spinal or epidural anesth.) Are providers at your affiliate using a mask? Reason: 3 pts. S. salivarius meningitis; mask not used by HCP Chitnis AS, et al. Outbreak of bacterial meningitis among patients undergoing myelography at an outpatient radiology clinic. J Am Coll Radiol. 2012 Mar;9(3):185-90 Transmission-based Precautions Used in addition to Standard Precautions Airborne Contact Droplet Infection Prevention Strategies Hierarchy of Controls Administrative Controls: Respiratory Hygiene + cough etiquette Environmental Controls: HVAC, AIIR# Personal Protective Equipment # Heating, Ventilation and Air Conditioning ; Airborne Infection Isolation Room Airborne Precautions For infections spread by particles that remain suspended in the air (TB, measles, varicella [chickenpox]) Airborne Infection Isolation Room (AIIR) (a.k.a. “negative pressure room”) Surgical mask on patient if necessary to leave room Respiratory protection for healthcare personnel (HCP) in AIIR: N95 or more efficient respirator – e.g. patient with active TB disease, SARS-CoV – 2007 Isol. Prec. Table For measles & chickenpox – only immune HCP should care for patient; New evidence: HCP should wear N95! Gohil SK CID 2015; immune personnel developed occupational infection AIIR exhaust should not be re-circulated in the building; if filtered using HEPA media = OK Contact Precautions For infections spread by direct or indirect contact with patients or patient care environment (e.g., RSV, C. difficile, MRSA, VRE, CRE, MDR-A. baumannii). Limit patient movement Private room preferred Cohort patients with the same infection status Don gown and gloves before entering the patient room Remove and discard gown and gloves inside the patient room Hand hygiene immediately after leaving the patient room Emphasis on cleaning, esp. frequently touched surfaces (bed rails, bedside tables, lavatory surfaces, etc.). Dedicated equipment whenever possible (e.g., stethoscopes) Does hand hygiene compliance change when patients are in contact precaution rooms in ICUs?; Gilbert J, et al. AJIC 2010 No! except MICU RNs more likely (66.7%) with CP vs (51.6%) without Droplet Precautions For infections spread by large droplets generated by coughs, sneezes, etc. (e.g., Neisseria meningitidis, pertussis, seasonal influenza). Face shield or goggles, and a surgical mask are worn to prevent droplets reaching the mucous membranes of the eyes, nose and mouth when within ~6 feet of the patient Patients should be separated by 3-6 feet, or be grouped with other patients with the same infection/colonization status Patient should wear a surgical mask when outside of the patient room AIIR is not needed Coughing and Masks Schlieren optics visualize the dispersion of expelled air during coughing Both standard mask (A) and N95 respirator (B) prevent dispersion of cough plume Without any type of mask plume travels 1-2 m Tang J W-T. N Engl J Med 2009;361;26 The Colonization “Iceberg” Effect Infected and symptomatic Colonized with Epidemiologically-significant microbe; no symptoms Colonized or Infected: What is the difference? People who carry bacteria without evidence of infection (e.g. fever, increased white blood cell count) are colonized If an infection develops, it is usually from bacteria that colonize patients Bacteria that colonize patients can be transmitted from one patient to another by the hands of healthcare workers ~ Bacteria can be transmitted even if the patient is not infected ~ Epidemiology of MDROs is NOT necessarily created equal nor the same across health care settings …no evidence supports the use of stringent barrier precautions to decrease illness or death from MDROs in LTCFs … Additional precautions are recommended for patients colonized …only when they are a documented source of transmission to others…e.g. MRSA in resident with extensive skin lesions that can’t be contained or VRE in lower GI tract + diarrhea/incontinence…” Residents with invasive devices, e.g. indwelling urinary catheter, feeding tube, more likely to have MDRO. Nicolle LE. Preventing Infections in non-hospital Settings: long-term care. Emerg Infect Dis 2001;7(no.2): 205-7. Wang L, et al. Eur J Clin Microbiol Infect Dis. 2012 Aug;31(8):1797-804 Epidemiology of MDROs in LTCF- Are Contact Precautions Effective? Setting: Residents in 122 bed skilled nursing facility in 667 bed hospital, IL Study Interventions: Contact-Isolation (CI) phase = gowns/gloves; not confined to room [+ for VRE, MRSA; no policy related to ESBL] Routine glove (RG) use phase = gloves for care of all residents or their environment; no contact isolation even if culture + Results: Frequency of acquisition of MDRO no different between CI vs RG; During RG phase personnel more likely to wear gloves, remove them, perform hand hygiene than during CI Trick WE, et al. Comparison of Routine glove use and C-I Precautions to prevent transMission of MD bacteria in a LTCF. J Am Geriatr Soc 2004; 52:2003-9. Supply costs: Gowns (15/day) CI = $92,900/yr Gloves with RG = $2,415/yr Take home messages: RG preferred over CI, no incr. Risk, and more cost effective. Contact Precautions (CP) & Patient Safety Paradox: Acute Care Setting Case Control Study: adult patients on CP for MRSA; 2 large teaching hospitals Care Process Results: Vital signs incomplete or absent when on CP More days with no RN or MD progress notes when on CP Outcomes & Satisfaction: Freq. of adverse events 2x higher if on CP Falls, pressure ulcers, fluid/electrolyte disorders = 8x higher vs. controls Patient dissatisfaction: 17-38% on CP vs 3-5% for controls Stelfox HT. JAMA 2003; 290:1899-1905 Problematic Pathogens In the Healthcare Setting & Beyond Vancomycinresistant enterococci (VRE)1 Methicillinresistant S. aureus (MRSA)2 C. difficile3 Norovirus4 1 2 3 4 12 Step Program for “Antibiotics Anonymous” http://www.mi-marr.org/LTC_toolkit.html MARR Long-term Care Tool Kit: PREVENT INFECTION Step 1: Vaccinate Step 2: Prevent conditions that lead to infection Step 3: Get the unnecessary devices out DIAGNOSE AND TREAT INFECTION EFFECTIVELY Step 4: Use established criteria for diagnosis Step 5: Use local resources USE ANTIMICROBIALS WISELY Step 6: Know when to say "no" Step 7: Treat infection, not colonization/contamination Step 8: Stop antimicrobial treatment PREVENT TRANSMISSION Step 9. Isolate the pathogen Step 10. Break the chain of contagion Step 11. Perform hand hygiene Step 12. Identify resident with multidrug-resistant organisms (MDROs) MDROs in LTCFs The epidemiology of MDROs in LTCF differs from other settings such as acute care. This primarily reflects much less frequent use of invasive devices and severity of underlying illness. Therefore while presence of MDROs among residents may be high, risk of cross transmission is low compared to acute care. State of MI Bureau of Health Systems, MDCH, 10/03/2001 Guidelines for Care of Nursing Home Residents with antimicrobial-resistant organisms (ARO) including MRSA & VRE Use Standard Precautions Communication of infection/colonization when transferring or admitting a resident is essential No regulation requires negative cultures as prerequisite for admission to LTCF, and federal/state rules prohibit same. MI Society for Infection Prevention & Control. Guidelines for Prevention & Control of ARO. 2002 CDC Recommendations: MDRO in LTCFs; 2006 In LTCFs, consider the individual patient’s clinical situation and prevalence or incidence of MDRO in the facility when deciding whether to implement or modify Contact Precautions in addition to Standard Precautions for a patient infected or colonized with a target MDRO. For relatively healthy residents (e.g., mainly independent and perhaps colonized with MDRO) follow Standard Precautions CDC Recommendations: MDRO in LTCFs; 2006 For ill residents (e.g., those totally dependent upon healthcare personnel for healthcare and activities of daily living, ventilator-dependent) and for those residents whose infected secretions or drainage cannot be contained, use Contact Precautions in addition to Standard Precautions. For MDRO colonized or infected patients without draining wounds, diarrhea, or uncontrolled secretions, establish ranges of permitted ambulation, socialization, and use of common areas based on your facility-based risk assessment Step 6: Know when to say “no” Minimize use of broad-spectrum antibiotics Avoid chronic or long-term antimicrobial prophylaxis Develop a system to monitor antibiotic use and provide feedback to appropriate personnel See also new checklist from CDC; The Core Elements of Antibiotic Stewardship for Nursing Homes, 09/2015 Defining Epidemiologically Important Pathogens 2006 CDC/HICPAC MDRO Guide Infectious agents that have one or more of the following characteristics: 1) A propensity for transmission within healthcare facilities 2) Antimicrobial resistance implications 3) Associated with serious clinical disease increased morbidity and mortality 4) A newly discovered or reemerging pathogen Why We Should Use Concept of Epidemiologically Important Pathogen? Some bad pathogens in healthcare really are not multi-drug resistant: – methicillin susceptible S. aureus (MSSA) – Group A Streptococcus – Clostridium difficile Strategies described to control MDROs are often applied to control epidemiologically important organisms other than MDROs. Pathogen Profile - Hospital A: Cent. Line-Assoc Bloodstream Infection (CLABSI), All Units 10/06-09/07 35 30 % of 25 Cases 20 of CLABSI 15 10 5 0 MRSA MSSA SSN Ents Gm neg Candida Clostridium difficile infection by Patient Care Unit, Hospital A Unit 4E 8E 5E 2000 MICU Annual SJMH Rate 2009 Annual Unit Rate 2008 10 E 9E 4000 3E SICU CCU 2E 7E 6E 60 55 50 45 40 35 30 25 20 15 10 5 0 11 E Rate per 10,000 Pt Days Figure 1: Rates of CDI HCF onset HCF assoc by Patient Care Unit, '08 & '09 Active Sureillance Cultures – Look Before you Leap Availability of private rooms Staffing needs: direct care & IPCS Monitoring adherence with contact precautions by personnel Preventing unintended consequences of placing patients in contact precautions Decolonization therapy? Tracking of those positive for target MDROs & electronic alert system for subsequent readmissions? Diekema DJ, Edmond MB. Clin Infect Dis 2007;44 (April 15) 62% decrease in healthcare-assoc. MRSA infection in ICUs and 45% in non-ICUs, VAMCs with active surveillance + CP Jain R, et al. NEJM 2011 Tale of Two Studies on Efficacy of Active Surveillance for MDROs No significant difference in incidence of MDRO between intervention (ASD) & control ICUs Huskins WC, NEJM 2011